Wellington Management Group
ZNTL icon

Wellington Management Group’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Wellington Management Group’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24,301
Closed -$99.4K – 2042
2024
Q2 		$99.4K Buy
+24,301
New +$271K ﹤0.01% 1870
2024
Q1 		– Sell
-68,791
Closed -$1.04M – 1984
2023
Q4 		$1.04M Sell
68,791
-1,848,314
-96% -$27M ﹤0.01% 1618
2023
Q3 		$38.5M Buy
1,917,105
+8,661
+0.5% +$220K 0.01% 761
2023
Q2 		$53.8M Sell
1,908,444
-1,451,885
-43% -$34.8M 0.01% 689
2023
Q1 		$57.8M Sell
3,360,329
-258,164
-7% -$5.23M 0.01% 663
2022
Q4 		$72.9M Buy
3,618,493
+496,129
+16% +$10.7M 0.01% 597
2022
Q3 		$67.6M Buy
3,122,364
+1,737,660
+125% +$47.5M 0.01% 602
2022
Q2 		$38.9M Buy
1,384,704
+1,093,245
+375% +$29M 0.01% 745
2022
Q1 		$13.4M Buy
291,459
+139,014
+91% +$7.5M ﹤0.01% 1124
2021
Q4 		$12.8M Buy
152,445
+17,834
+13% +$1.38M ﹤0.01% 1189
2021
Q3 		$8.97M Buy
134,611
+46,381
+53% +$2.68M ﹤0.01% 1328
2021
Q2 		$4.69M Buy
+88,230
New +$4.73M ﹤0.01% 1518

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group's ZNTL Position: Q3 2024 in Review

Wellington Management Group sold out of Zentalis Pharmaceuticals (ZNTL) in Q3 2024, closing a stake of 24,301 shares — an estimated $99.4K sold.

Wellington Management Group first reported a position in ZNTL in Q2 2021 and held it in 12 quarters. The position peaked at $72.9M in Q4 2022. 136 funds tracked by Wall St. Rank hold ZNTL as of Q3 2024.

  • Wellington Management Group reported no remaining Zentalis Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Wellington Management Group sold 24,301 Zentalis Pharmaceuticals shares in Q3 2024, an estimated $99.4K.
  • Wellington Management Group first reported a position in Zentalis Pharmaceuticals in Q2 2021 and held it in 12 quarters.
  • Wellington Management Group's Zentalis Pharmaceuticals position peaked at $72.9M in Q4 2022.
  • 136 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2024.

Based on Wellington Management Group's 13F filing for Q3 2024, filed 14 Nov 2024.